Position in AZN
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$253,521
New position
Shares Held
1,337
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#1,110
of 1,459 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Revolve Wealth Partners, LLC holds $14,063,282 across 9 Drug Manufacturers - General names. AZN ranks #8 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
12,937 | $4,684,746 | |
| 2 | JNJ |
Johnson & Johnson
|
12,023 | $3,053,481 | |
| 3 | LLY |
ELI LILLY & Co
|
1,757 | $2,107,398 | |
| 4 | ABBV |
AbbVie Inc.
|
7,998 | $2,012,616 | |
| 5 | MRK |
Merck & Co., Inc.
|
5,669 | $728,466 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
5,473 | $691,458 | |
| 7 | PFE |
Pfizer Inc
|
12,536 | $301,866 | |
| 8 | AZN |
Astrazeneca PLC
This page
|
1,337 | $253,521 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $253,521 | 1,337 | Shares | Sole | 2026-07-09 | |
| No filing history on record for this holder in this stock. | ||||||